NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
Back to search
Official data from USPTO
INFLEXIONRX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INFLEXIONRX
ST13
US500000079322621Class
9, 42
Filing
79322621
Registration
7416079
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
02/20/2026
Trademark type
Word
Nice classes
9, 42
Filing date
03/15/2021
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
GADSON, SHARI B.
Law office
N20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Prescient Healthcare Group Limited
Representatives
Patrick C. Stephenson Kutak Rock LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
downloadable software for receivingreviewingorganizingstoringsharingdownloading and editing competitive informationintelligenceinsightsnewsregulatory informationscientific informationclinical datamarket data and social media data relating to the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries; downloadable software for use in receiving consulting and advisory services and collaborating with consultantsadvisors and internal resources in the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries
Class 42
Providing on-line non-downloadable software for receivingreviewingorganizingstoringsharingdownloading and editing competitive informationintelligenceinsightsnewsregulatory informationscientific informationclinical datamarket data and social media data relating to the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries; providing on-line non-downloadable software for use in receiving consulting and advisory services and collaborating with consultantsadvisors and internal resources in the medical devicesmedical technologypharmaceuticalbiotechnology and biopharmaceuticals industries
Publications
History of USPTO decisions and trademark events.
44 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/05/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/14/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/22/2024
FIMP
FINAL DISPOSITION PROCESSED
11/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/20/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/02/2023
GNRT
NON-FINAL ACTION E-MAILED
11/02/2023
CNRT
NON-FINAL ACTION WRITTEN
11/02/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/31/2023
DOCK
ASSIGNED TO EXAMINER
08/28/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/26/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/15/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/15/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/06/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/08/2022
GNSL
LETTER OF SUSPENSION E-MAILED
06/08/2022
CNSL
SUSPENSION LETTER WRITTEN
06/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2022
RFNT
REFUSAL PROCESSED BY IB
12/07/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/16/2021
RFRR
REFUSAL PROCESSED BY MPU
11/15/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/21/2021
CNRT
NON-FINAL ACTION WRITTEN
10/20/2021
DOCK
ASSIGNED TO EXAMINER
10/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/14/2021
Continuous trademark protection
Get notified about every new filing that threatens INFLEXIONRX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.